Orange Book product · Generic (ANDA)
LOMUSTINE
LOMUSTINE
Generic (ANDA)ANDA 219265TE ABRX CARNEGIE
At a glance
Oct 27, 2025
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 27, 2025
8 mo ago
Exclusivity ends · CGT
FDA marketing exclusivity
May 19, 2026
1 mo ago
Today
Pharmaceutical detail
Active ingredient
LOMUSTINE
Strength
40MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 219265
Product number
002
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LOMUSTINE
Marketing exclusivity (1)
- CGTFDA marketing exclusivity
May 19, 2026
1 mo ago
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
